Buy Genetic Technologies Stock | GENE Stock Price & Latest News | Public
GENE

Genetic Technologies

$0.00 (0.00%)Today
    Small Market Cap

    About GENE

    Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The c...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Stats

    Market Cap$51,36M
    Volume9,43k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$10.30
    1 Year Low$1.41
    Open$3.68
    High$3.68
    Low$3.57

    Buy any stock with any amount of money.

    Download the App
    Download the app